# OnCo record nct04929041 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04929041/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04929041", "NCT04929041" ;
  schema:name "Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Pati"@en ;
  schema:description "A phase 2/3 trial of ipilimumab and nivolumab in lung cancer, run by National Cancer Institute (NCI), active but no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04929041/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04929041> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest", "lung-deep-dive" ;
  onco:phase "2/3" ;
  onco:cancers <https://onco.cc/cancers/lung-adenocarcinoma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/nivolumab/> .